76 related articles for article (PubMed ID: 24333413)
1. Krüppel-like transcription factor 11 (KLF11) overexpression inhibits cardiac hypertrophy and fibrosis in mice.
Zheng Y; Kong Y; Li F
Biochem Biophys Res Commun; 2014 Jan; 443(2):683-8. PubMed ID: 24333413
[TBL] [Abstract][Full Text] [Related]
2. KLF15 protects against isoproterenol-induced cardiac hypertrophy via regulation of cell death and inhibition of Akt/mTOR signaling.
Gao L; Guo Y; Liu X; Shang D; Du Y
Biochem Biophys Res Commun; 2017 May; 487(1):22-27. PubMed ID: 28336438
[TBL] [Abstract][Full Text] [Related]
3. The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice.
Qiao W; Zhang W; Gai Y; Zhao L; Fan J
Biochem Biophys Res Commun; 2014 Jun; 448(4):379-84. PubMed ID: 24802406
[TBL] [Abstract][Full Text] [Related]
4. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y
Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320
[TBL] [Abstract][Full Text] [Related]
5. Mouse KLF11 regulates hepatic lipid metabolism.
Zhang H; Chen Q; Yang M; Zhu B; Cui Y; Xue Y; Gong N; Cui A; Wang M; Shen L; Zhang S; Fang F; Chang Y
J Hepatol; 2013 Apr; 58(4):763-70. PubMed ID: 23183531
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
7. HSP75 protects against cardiac hypertrophy and fibrosis.
Zhang Y; Jiang DS; Yan L; Cheng KJ; Bian ZY; Lin GS
J Cell Biochem; 2011 Jul; 112(7):1787-94. PubMed ID: 21381076
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
9. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
Ohmura H; Yasukawa H; Minami T; Sugi Y; Oba T; Nagata T; Kyogoku S; Ohshima H; Aoki H; Imaizumi T
Hypertens Res; 2012 Nov; 35(11):1063-8. PubMed ID: 22763477
[TBL] [Abstract][Full Text] [Related]
11. Functional study of transcription factor KLF11 by targeted gene inactivation.
Song CZ; Gavriilidis G; Asano H; Stamatoyannopoulos G
Blood Cells Mol Dis; 2005; 34(1):53-9. PubMed ID: 15607700
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling.
Huang H; Tang QZ; Wang AB; Chen M; Yan L; Liu C; Jiang H; Yang Q; Bian ZY; Bai X; Zhu LH; Wang L; Li H
Hypertension; 2010 Aug; 56(2):232-9. PubMed ID: 20585109
[TBL] [Abstract][Full Text] [Related]
13. Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice.
Pei JF; Yan YF; Tang X; Zhang Y; Cui SS; Zhang ZQ; Chen HZ; Liu DP
Sci China Life Sci; 2016 Nov; 59(11):1115-1122. PubMed ID: 27578362
[TBL] [Abstract][Full Text] [Related]
14. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
[TBL] [Abstract][Full Text] [Related]
15. A novel role of the Sp/KLF transcription factor KLF11 in arresting progression of endometriosis.
Daftary GS; Zheng Y; Tabbaa ZM; Schoolmeester JK; Gada RP; Grzenda AL; Mathison AJ; Keeney GL; Lomberk GA; Urrutia R
PLoS One; 2013; 8(3):e60165. PubMed ID: 23555910
[TBL] [Abstract][Full Text] [Related]
16. Genetic Deletion of Krüppel-Like Factor 11 Aggravates Ischemic Brain Injury.
Tang X; Liu K; Hamblin MH; Xu Y; Yin KJ
Mol Neurobiol; 2018 Apr; 55(4):2911-2921. PubMed ID: 28456933
[TBL] [Abstract][Full Text] [Related]
17. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes.
Wenzel S; Henning K; Habbig A; Forst S; Schreckenberg R; Heger J; Maxeiner H; Schlüter KD
Basic Res Cardiol; 2010 Sep; 105(5):621-9. PubMed ID: 20556404
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction.
Hill C; Würfel A; Heger J; Meyering B; Schlüter KD; Weber M; Ferdinandy P; Aronheim A; Schulz R; Euler G
Cardiovasc Res; 2013 Jul; 99(1):121-8. PubMed ID: 23612584
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice.
Tsoporis JN; Marks A; Kahn HJ; Butany JW; Liu PP; O'Hanlon D; Parker TG
J Clin Invest; 1998 Oct; 102(8):1609-16. PubMed ID: 9788975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
